0001127602-12-034773.txt : 20121220
0001127602-12-034773.hdr.sgml : 20121220
20121220163735
ACCESSION NUMBER: 0001127602-12-034773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121218
FILED AS OF DATE: 20121220
DATE AS OF CHANGE: 20121220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haluska Frank
CENTRAL INDEX KEY: 0001494892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 121277698
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-12-18
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001494892
Haluska Frank
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
SVP, Clinical R&D, CMO
Common Stock
2012-12-18
4
M
0
12750
0
A
62531
D
Common Stock
2012-12-18
4
F
0
5324
20.18
D
57207
D
Shares were acquired upon vesting of performance share units awarded on April 1, 2011.
Represents shares withheld to satisfy withholding tax requirements related to the vesting of performance share units.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2012-12-19